KANSAS CITY, Mo., May 7, 2015 (GLOBE NEWSWIRE) -- Cerner Corporation (Nasdaq:CERN) today announced results for the 2015 first quarter that ended April 4, 2015.

Bookings in the first quarter of 2015 were $1.20 billion, an all-time high and an increase of 32 percent compared to $910.2 million in first quarter 2014.

First quarter revenue was $996.1 million, an increase of 27 percent compared to $784.8 million in the year-ago period. Revenue was below guidance provided by the Company due to a combination of lower than expected revenue from the recently closed acquisition of Siemens Health Services (Health Services) and lower revenue in our existing business. However, the lower revenue did not have a material impact on profitability, and Cerner's adjusted earnings were in-line with guidance.

On a U.S. Generally Accepted Accounting Principles (GAAP) basis, first quarter 2015 net earnings were $110.9 million and diluted earnings per share were $0.32. First quarter 2014 GAAP net earnings were $119.5 million and diluted earnings per share were $0.34.

Adjusted (non-GAAP) Net Earnings

Adjusted net earnings for first quarter 2015 were $157.1 million, compared to $129.1 million of adjusted net earnings in the first quarter of 2014. Adjusted diluted earnings per share were $0.45 in the first quarter of 2015, an increase of 22 percent compared to $0.37 of adjusted diluted earnings per share in the year-ago quarter. Analysts' consensus estimate for first quarter 2015 adjusted diluted earnings per share was $0.45.

Adjusted net earnings is not a recognized term under GAAP and should not be substituted for net earnings as a measure of Cerner's performance but instead should be utilized as a supplemental measure of financial performance in evaluating our business. Following is a description of adjustments made to net earnings. For more detail, please see the accompanying schedule, titled "Reconciliation of GAAP Results to Non-GAAP Results."

First quarter 2015 adjusted net earnings and diluted earnings per share exclude share-based compensation expense, which reduced first quarter 2015 net earnings and diluted earnings per share by $10.9 million and $0.03, respectively. Adjusted net earnings and diluted earnings per share also reflect adjustments related to Cerner's acquisition of Health Services, including: amortization of intangibles, which reduced net earnings and diluted earnings per share by $10.0 million and $0.03, respectively; a deferred revenue adjustment, which reduced net earnings and diluted earnings per share by $8.3 million and $0.02, respectively; and other acquisition-related adjustments, which reduced net earnings and diluted earnings per share by $16.9 million and $0.05, respectively.

Other 2015 First Quarter Highlights:
  • First quarter cash collections of $981.2 million and operating cash flow of $214.2 million.
  • First quarter free cash flow of $68.9 million. Free cash flow is a non-GAAP financial measure defined as GAAP cash flows from operating activities less capital purchases and capitalized software development costs. For more detail, please see the accompanying schedule, titled "Reconciliation of GAAP Results to Non-GAAP Results."
  • First quarter days sales outstanding of 79 days, which is up from 66 days in the year-ago quarter.
  • Total backlog of $13.0 billion, up 41 percent over the year-ago quarter.

"Cerner's first quarter results represent a solid start to the year," said Neal Patterson, Cerner chairman, CEO and co-founder. "With the exception of lower than expected revenue, all of our results were at or above expected levels, with bookings being particularly strong and representing an all-time high. The record bookings reflect great success at attaining new clients, both domestically and around the world, and position us for a good year."

Future Period Guidance

Cerner currently expects:
  • Second quarter 2015 revenue between $1.175 billion and $1.225 billion.
  • Full year 2015 revenue between $4.65 billion and $4.8 billion, as compared to a prior range of $4.8 billion to $5.0 billion.
  • Second quarter 2015 adjusted diluted earnings per share before share based compensation expense and acquisition related adjustments between $0.51 and $0.52. 
  • Full year 2015 adjusted diluted earnings per share before share based compensation expense and acquisition-related adjustments between $2.07 and $2.15, as compared to a prior range of $2.05 to $2.15.
  • Second quarter 2015 new business bookings between $1.2 billion and $1.3 billion.
  • Share based compensation expense to reduce diluted earnings per share by approximately $0.03 to $0.04 in the second quarter of 2015 and between $0.14 and $0.16 for the year.

Earnings Conference Call

Cerner will host an earnings conference call to provide additional detail on these results at 3:30 p.m. CT on May 7. The dial-in number for the conference call is (857)-244-7326; the passcode is Cerner. Cerner recommends joining the call 15 minutes early for registration. The re-broadcast of the call will be available from 7:30 p.m. CT, May 7 through 11:59 p.m. CT, May 10. The dial-in number for the re-broadcast is (617)-801-6888; the passcode is 92323471.

An audio webcast will be available live and archived on Cerner's website at www.cerner.com under the About Cerner section (click Investor Relations, then Presentations and Webcasts).

About Cerner

Cerner's health information technologies connect people, information, and systems, at more than 18,000 facilities worldwide. Recognized for innovation, Cerner solutions assist clinicians in making care decisions and enable organizations to manage the health of populations. The company also offers an integrated clinical and financial system to help health care organizations manage revenue, as well as a wide range of services to support clients' clinical, financial and operational needs. Cerner's mission is to contribute to the systemic improvement of health care delivery and the health of communities. On February 2, 2015, Cerner Corporation acquired substantially all of the assets, and assumed certain liabilities, of the Siemens Health Services business from Siemens AG. (Nasdaq:CERN). For more information about Cerner, visit www.cerner.com, read our blog at www.cerner.com/blog, connect with us on Twitter at http://www.twitter.com/cerner and on Facebook at www.facebook.com/cerner.

Certain trademarks, service marks and logos set forth herein are property of Cerner Corporation and/or its subsidiaries. All other non-Cerner marks are the property of their respective owners.

All statements in this press release that do not directly and exclusively relate to historical facts constitute forward-looking statements. These forward-looking statements are based on the current beliefs, expectations and assumptions of Cerner's management with respect to future events and are subject to a number of significant risks and uncertainties. It is important to note that Cerner's performance, and actual results, financial condition or business could differ materially from those expressed in such forward-looking statements. The words "position", "guidance", "future", "expects", or the negative of these words, variations thereof or similar expressions are intended to identify such forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to: the possibility of product-related liabilities; potential claims for system errors and warranties; the possibility of interruption at our data centers or client support facilities; our proprietary technology may be subject to claims for infringement or misappropriation of intellectual property rights of others, or may be infringed or misappropriated by others; material adverse resolution of legal proceedings; risks associated with our non-U.S. operations; risks associated with our ability to effectively hedge exposure to fluctuations in foreign currency exchange rates; the potential for tax legislation initiatives that could adversely affect our tax position and/or challenges to our tax positions in the United States and non-U.S. countries; risks associated with our recruitment and retention of key personnel; risks related to our dependence on third party suppliers; risks inherent with business acquisitions and combinations and the integration thereof, such as difficulties and operational and financial risks associated with integrating Cerner and the Siemens Health Services business acquired from Siemens AG (the "Acquisition"); the potential for losses resulting from asset impairment charges; risks associated with volatility and disruption resulting from global economic conditions; managing growth in the new markets in which we offer solutions, health care devices and services; incurring significant additional expenses relating to the integration of the Health Services business into Cerner; compliance with restrictive covenants in our debt agreements, which may restrict our flexibility to operate our business; changing political, economic, regulatory and judicial influences; government regulation; significant competition and market changes; variations in our quarterly operating results; potential inconsistencies in our sales forecasts compared to actual sales; volatility in the trading price of our common stock and the timing and volume of market activity; our directors' authority to issue preferred stock and the anti-takeover provisions in our corporate governance documents; risks related to disruption of management time from ongoing business operations due to the integration of the business acquired in the Acquisition; failure to realize the synergies and other benefits expected from the Acquisition; risk that the assets and business acquired may not continue to be commercially successful; the effect of the Acquisition on the ability of Cerner to retain customers and retain and hire key personnel and maintain relationships with key suppliers; unexpected costs, charges or expenses resulting from the Acquisition; and litigation or claims relating to the Acquisition or the acquired assets and business. Additional discussion of these and other risks, uncertainties and factors affecting Cerner's business is contained in Cerner's filings with the Securities and Exchange Commission. The reader should not place undue reliance on forward-looking statements, since the statements speak only as of the date that they are made. Cerner undertakes no obligation to update forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes in future operating results, financial condition or business over time.
CERNER CORPORATION AND SUBSIDIARIES    
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS    
For the three months ended April 4, 2015 and March 29, 2014    
(unaudited)    
     
(In thousands, except per share data) Three Months Ended
  2015 (1) 2014 (1)
Revenues    
System sales  $ 259,569  $ 206,687
Support, maintenance and services  718,370  557,429
Reimbursed travel  18,150  20,645
Total revenues  996,089  784,761
     
Margin    
System sales  168,070  141,574
Support, maintenance and services  659,359  514,088
Total margin  827,429  655,662
     
Operating expenses    
Sales and client service  420,182  330,901
Software development  127,271  91,545
General and administrative  113,064  55,213
Total operating expenses  660,517  477,659
     
Operating earnings  166,912  178,003
     
Other income, net  208  2,990
     
Earnings before income taxes  167,120  180,993
Income taxes  (56,186)  (61,467)
Net earnings  $ 110,934  $ 119,526
     
Basic earnings per share  $ 0.32  $ 0.35
     
Basic weighted average shares outstanding  343,216  343,701
     
Diluted earnings per share  $ 0.32  $ 0.34
     
Diluted weighted average shares outstanding  351,659  352,230
     
Note 1: Operating expenses for the three months ended April 4, 2015 and March 29, 2014 include share-based compensation expense. The impact of this expense on net earnings and diluted earnings per share is presented below:
     
     
(In thousands, except per share data) Three Months Ended
  2015 2014
     
Sales and client service  $ 8,540  $ 7,218
Software development  2,954  3,085
General and administrative  4,963  4,465
Total share-based compensation  16,457  14,768
Amount of related income tax benefit  (5,533)  (5,184)
Net impact on net earnings  $ 10,924  $ 9,584
     
Decrease to diluted earnings per share  $ 0.03  $ 0.03
     
CERNER CORPORATION AND SUBSIDIARIES    
RECONCILIATION OF GAAP RESULTS TO NON-GAAP RESULTS1    
For the three months ended April 4, 2015 and March 29, 2014    
(unaudited)    
     
RECONCILIATION OF ADJUSTED NET EARNINGS TO GAAP NET EARNINGS1    
     
(In thousands) Three Months Ended
  2015 2014
Net Earnings    
Net earnings (GAAP)  $ 110,934  $ 119,526
Share-based compensation expense, net of tax  10,924  9,584
Acquisition-related amortization, net of tax2  10,035  —
Acquisition-related deferred revenue adjustment, net of tax3  8,298  —
Other acquisition-related adjustments, net of tax4  16,879  —
Adjusted net earnings (non-GAAP)5  $ 157,070  $ 129,110
     
RECONCILIATION OF ADJUSTED DILUTED EARNINGS PER SHARE TO GAAP DILUTED EARNINGS PER SHARE1    
     
  Three Months Ended
  2015 2014
Diluted Earnings Per Share    
Diluted earnings per share (GAAP)  $ 0.32  $ 0.34
Share-based compensation expense, net of tax  0.03  0.03
Acquisition-related amortization, net of tax2  0.03  —
Acquisition-related deferred revenue adjustment, net of tax3  0.02  —
Other acquisition-related adjustments, net of tax4  0.05  —
Adjusted diluted earnings per share (non-GAAP)5  $ 0.45  $ 0.37
     
RECONCILIATION OF NON-GAAP FREE CASH FLOW TO GAAP OPERATING CASH FLOW1    
     
(In thousands) Three Months Ended
  2015 2014
Cash flows from operating activities (GAAP)  $ 214,247  $ 155,787
Capital purchases  (82,264)  (69,661)
Capitalized software development costs  (63,067)  (44,544)
Free cash flow (non-GAAP)6  $ 68,916  $ 41,582
     
     
Note 1: The presentation of Adjusted Diluted Earnings per Share, Adjusted Net Earnings and Free Cash Flow, non-GAAP financial measures, are not meant to be considered in isolation, nor as a substitute for, or superior to, Generally Accepted Accounting Principles (GAAP) results and investors should be aware that non-GAAP measures have inherent limitations and should be read only in conjunction with Cerner's consolidated financial statements prepared in accordance with GAAP. Adjusted Diluted Earnings per Share, Adjusted Net Earnings and Free Cash Flow may also be different from similar non-GAAP financial measures used by other companies and may not be comparable to similarly titled captions of other companies due to potential inconsistencies in the method of calculations. We believe that Adjusted Diluted Earnings per Share, Adjusted Net Earnings and Free Cash Flow are important to enable investors to better understand and evaluate our ongoing operating results and allows for greater transparency in the review and understanding of our overall financial, operational and economic performance.
     
Note 2: The Health Services acquisition-related amortization is presented net of income tax benefits of $5.1 million for the three months ended April 4, 2015.
     
Note 3: The Health Services acquisition-related deferred revenue adjustment is presented net of income tax benefits of $4.2 million for the three months ended April 4, 2015.
     
Note 4: Other acquisition-related adjustments (includes acquisition and employee separation costs) are presented net of income tax benefits of $8.5 million for the three months ended April 4, 2015.
     
Note 5: Cerner provides earnings with and without share-based compensation expense and acquisition-related adjustments because earnings excluding these amounts are used by management along with GAAP results to analyze its business, make strategic decisions, assess long-term trends on a comparable basis, and for management compensation purposes.
     
Note 6: Cerner provides free cash flow because it takes into account the capital expenditures necessary to operate our business.
     
CERNER CORPORATION AND SUBSIDIARIES    
CONDENSED CONSOLIDATED BALANCE SHEETS    
As of April 4, 2015 (unaudited) and January 3, 2015    
     
(In thousands) 2015 2014
     
Assets    
Current assets:    
Cash and cash equivalents  $ 390,335  $ 635,203
Short-term investments  293,827  785,663
Receivables, net  940,571  672,778
Inventory  22,553  23,789
Prepaid expenses and other  242,462  209,278
Deferred income taxes, net  21,533  22,075
Total current assets  1,911,281  2,348,786
     
Property and equipment, net  1,103,400  924,260
Software development costs, net  456,473  420,199
Goodwill  767,222  320,538
Intangible assets, net  741,162  126,636
Long-term investments  204,520  231,147
Other assets  168,547  158,999
Total assets  $ 5,352,605  $ 4,530,565
     
Liabilities and Shareholders' Equity    
Current liabilities:    
Accounts payable  $ 195,711  $ 160,285
Current installments of long-term debt and capital lease obligations  61,828  67,460
Deferred revenue  301,907  209,655
Accrued payroll and tax withholdings  182,222  140,230
Other accrued expenses  50,631  56,685
Total current liabilities  792,299  634,315
     
Long-term debt and capital lease obligations  564,339  62,868
Deferred income taxes and other liabilities  258,746  256,601
Deferred revenue  26,800  10,813
Total liabilities  1,642,184  964,597
     
Shareholders' Equity:    
Common stock  3,486  3,470
Additional paid-in capital  985,073  933,446
Retained earnings  3,029,415  2,918,481
Treasury stock  (245,333)  (245,333)
Accumulated other comprehensive loss, net  (62,220)  (44,096)
Total shareholders' equity  3,710,421  3,565,968
Total liabilities and shareholders' equity  $ 5,352,605  $ 4,530,565
CONTACT: Investor Contact:         Allan Kells, (816) 201-2445, akells@cerner.com         Media Contact:         Dan Smith, (913) 304-3991, dan.smith1@cerner.com         Cerner's Internet Home Page:         www.cerner.com

Cerner logo